Pseudoephedrine - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : Pseudoephedrine – Risks of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS)

Dissemination date: 09/02/2024

Key facts

• Active substance:
  Pseudoephedrine
• Therapeutic area (MeSH):
  Nasal Decongestants
• Procedure number:
  EMEA/H/A-31/1526
• Regulatory outcome:
  Variation
• DHPC type:
  Referral - Article 31
• Referral name:
  Pseudoephedrine-containing medicinal products
• Human ATC codes:
  R01BA02
• Dissemination date:
  09/02/2024
• Related medicines:
  Pseudoephedrine-containing medicinal products